RECRUITING

Study of Skeletal Disorders

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Background: There are 461 conditions that affect the bones (skeletal disorders). Many of these are not well understood and do not have any specific treatments. Researchers want to collect more data about these conditions. Objective: To gain more information about the causes of skeletal disorders and how they progress over time. Eligibility: People ages 2 months or older with known or suspected skeletal disorders or history of pregnancy affected by skeletal findings. Also, healthy family members of affected enrolled participants. Design: Participants can take part in the study either remotely or in person. Those who take part remotely may send in medical records, blood samples, photographs, and other materials. Participants medical records will be reviewed. They may give blood and/or urine samples. They will give blood, saliva, or tissue samples for genetic tests. They may have genetic counseling. Participants ages 2 years and older may have different kinds of imaging scans, such as x-rays. For these scans, they may have to lie still while machines take pictures of their bones. Participants with skeletal disorders who come to the clinic will be examined. They may be asked to stay in the hospital for a few days to take extra tests. They may have a bone or skin biopsy. Participants with skeletal disorders may be photographed to show the effects of their disorder and how it changes over time. For participants with skeletal disorders, their blood or tissue samples may be used to make a special type of stem cell. These cells can be used in the laboratory to make many other types of cells. A large supply of these cells may be created for research. Participation will last indefinitely.

Official Title

Clinical and Laboratory Study of Rare Skeletal Disorders

Quick Facts

Study Start:2022-01-18
Study Completion:2026-07-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05031507

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:2 Months to 100 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:CHILD, ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Individuals with a skeletal disorder that affects phosphate levels and/or metabolism
  2. * Individuals with a skeletal disorder associated with skeletal overgrowth
  3. * Individuals with a skeletal disorder or history of pregnancy affected by skeletal findings with an unknown molecular basis or unknown etiology
  4. 1. Have a known (via clinical, radiographic or molecular diagnosis) or suspected skeletal disorder, findings associated with or increasing risk for skeletal abnormalities, or history of pregnancy affected by skeletal findings
  5. 2. State willingness to comply with study procedures and availability for the duration of the study
  6. 3. Be age 2 months or older
  7. 4. Be able to understand and sign informed consent document (or availability of a parent/guardian or LAR to provide written consent)
  8. 1. Be an unaffected family member of an affected enrolled subject
  9. 2. State willingness to comply with study procedures and availability for the duration of the study
  10. 3. Be age 2 months or older
  11. 4. Be able to understand and sign informed consent document (or availability of a parent/guardian)
  1. 1. An individual who cannot or is unwilling to abide by the procedures of the protocol.
  2. 2. An individual deemed to not have sufficient signs of or risks for skeletal disease.
  3. 3. An individual who is pregnant.
  4. 1. An individual who cannot or is unwilling to abide by the procedures of the protocol.
  5. 2. An individual that shows signs of skeletal disease.
  6. 3. An individual who is pregnant.

Contacts and Locations

Study Contact

Holly E Babcock
CONTACT
(301) 594-3391
holly.babcock@nih.gov
Carlos R Ferreira Lopez, M.D.
CONTACT
(240) 393-5441
ferreiracr@mail.nih.gov

Principal Investigator

Carlos R Ferreira Lopez, M.D.
PRINCIPAL_INVESTIGATOR
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Study Locations (Sites)

National Institutes of Health Clinical Center
Bethesda, Maryland, 20892
United States

Collaborators and Investigators

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

  • Carlos R Ferreira Lopez, M.D., PRINCIPAL_INVESTIGATOR, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-01-18
Study Completion Date2026-07-31

Study Record Updates

Study Start Date2022-01-18
Study Completion Date2026-07-31

Terms related to this study

Keywords Provided by Researchers

  • skeletal
  • Bone
  • Skeletal Dysplasia
  • Short Stature
  • DWARFISM
  • Natural History

Additional Relevant MeSH Terms

  • Skeletal Disorders